Advertisement
Table 3 Mean CBF and CBV for patients with symptomatic ICA occlusion, classified in haemodynamic stage 0 ( n = 10) and haemodynamic stage 1 or 2 ( n = 13)
| Intervention | Standard | Unadjusted difference in change (95% CI) | Adjusted difference in change *(95% CI) | ||
|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | ||||
| Haemodynamic stage 0 | N = 5 | N = 5 | |||
| CBF MCA (mL/min/100 mL) | Baseline | 37.0 ± 3.0 | 35.0 ± 5.6 | ||
| 3 months | 33.9 ± 5.8 | 34.4 ± 5.2 | |||
| Change | −3.1 ± 8.1 | −0.6 ± 5.3 | −2.5 (−12.5 to 7.4) | −1.7 (−15.6 to 12.2) | |
| CBV MCA (mL/100 mL) | Baseline | 3.1 ± 0.6 | 2.8 ± 0.7 | ||
| 3 months | 3.0 ± 0.7 | 3.5 ± 0.4 | |||
| Change | −0.2 ± 1.1 | 0.6 ± 1.0 | −0.8 (−2.3 to 0.7) | −1.1 (−3.2 to 1.1) | |
| Haemodynamic stage 1 or 2 | N = 7 | N = 6 | |||
| CBF MCA (mL/min/100 mL) | Baseline | 27.2 ± 3.4 | 31.5 ± 5.2 | ||
| 3 months | 30.0 ± 3.9 | 32.8 ± 4.6 | |||
| Change | 2.8 ± 3.1 | 1.3 ± 3.2 | 1.6 (−2.2 to 5.4) | −1.1 (−7.8 to 5.7) | |
| CBV MCA (mL/100 mL) | Baseline | 2.9 ± 0.6 | 3.7 ± 0.8 | ||
| 3 months | 4.0 ± 1.7 | 3.0 ± 0.6 | |||
| Change | 1.1 ± 1.9 | −0.7 ± 1.1 | 1.8 (−0.2 to 3.8) | 1.4 (−2.4 to 5.1) | |
